Skip to Main Content

Paper Details

Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial.
Eur Heart J Cardiovasc Pharmacother
7
2022
Patients, aspirin, cardiovascular death, coronary or peripheral arterial disease, multimorbidity, myocardial infarction, participants, patients, rivaroxaban, stroke
Author NameAffiliation
Sonia S AnandPopulation Health Research Institute, McMaster University and Hamilton Health Sciences
Keith A A FoxUniversity of Edinburgh
Deepak L BhattBrigham and Women's Hospital Heart and Vascular Center, Harvard Medical School
Salim YusufPopulation Health Research Institute, McMaster University and Hamilton Health Sciences
  • 1 - 4

Datasets

Release 1.2